Finance

Lists
Why is KAPA down 3.43%?
Dive Deeper
KAPA:NYSEAMERICAN
Kairos Pharma Ltd
$0.78
-3.43%
(-0.028) 1D
Oct 12, 1:20:45 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KAPA...
Open
$0.81
High
$0.83
Low
$0.74
Mkt. cap
2.73M
Avg. vol.
679.16K
Volume
183.50K
52-wk high
$9.17
52-wk low
$0.74
EPS
-$1.95
Shares outstanding
3.38M
No. of employees
3
Open
$0.81
High
$0.83
Low
$0.74
Mkt. cap
2.73M
Avg. vol.
679.16K
Volume
183.50K
52-wk high
$9.17
52-wk low
$0.74
EPS
-$1.95
Shares outstanding
3.38M
No. of employees
3
News stories
From web sources and news partners
About Kairos Pharma Ltd
CEO-
Employees3
Founded2013
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Websitekairospharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
608.00K
538.00K
684.00K
619.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
827.00K
877.00K
1.01M
798.00K
Operating expense
1.44M
1.42M
1.69M
1.42M
Total operating expenses
1.44M
1.42M
1.69M
1.42M
Operating income
-1.44M
-1.42M
-1.69M
-1.42M
Other non operating income
-
-
-
-
EBT including unusual items
-1.40M
-1.36M
-1.65M
-1.39M
EBT excluding unusual items
-1.40M
-1.36M
-1.65M
-1.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.40M
-1.36M
-1.65M
-1.39M
Net profit margin
-
-
-
-
Earnings per share
-0.49
-0.49
-0.56
-0.42
Interest and investment income
37.00K
50.00K
36.00K
29.00K
Interest expense
-
-
-
-
Net interest expenses
37.00K
50.00K
36.00K
29.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.40M
-1.38M
-1.65M
-1.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps